25-Gauge Vitrectomy With Ranibizumab or Triamcinolone Acetonide on Proliferative Diabetic Retinopathy in China
Status:
Unknown status
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
Proliferative diabetic retinopathy(PDR) is the leading cause of visual loss in diabetic
patients. Operation is an efficient method to treat PDR. Anti-vascular endothelial growth
factor (anti-VEGF) can be used as an adjuvant therapy which can make operation more easy.